Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Clinical trials sponsored by Jiangsu Alphamab Biopharmaceuticals Co., Ltd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug cocktail aims to tackle tough breast cancer Results expected Jun 2027 (estimated)
- New drug cocktail targets tough lung cancer Results expected Aug 2027 (estimated)
- New drug JSKN022 enters human testing for advanced cancers Results expected Aug 2027 (estimated)